Scintimammography with 99mTc-MIBI versus dynamic MRI for non-invasive characterization of breast masses

European Journal of Nuclear Medicine

Volumn 28, Issue 1, 2001, Pages 56-63

  Imbracio, M ^a   Del Vecchio, S ^a   Riccardi, A ^a   Pace, L ^a   Li Salle, F ^a   Di Gennaro, F ^a   Salvatore, M ^a   Sodano, A ^a  

^a Parco Flory Isolato 4   (Italy)

Author keywords

99mTc MIBI; Breast cancer; Magnetic resonance imaging; Scintimammography

Indexed keywords

GADOLINIUM PENTETATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; EARLY DIAGNOSIS; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SCINTIMAMMOGRAPHY; BIOPSY; BREAST TUMOR; CLINICAL TRIAL; COMPUTER ASSISTED DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; MAMMOGRAPHY; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SCINTISCANNING; STATISTICAL MODEL;

BIOPSY; BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; MODELS, STATISTICAL; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI;

EID: 0034746432     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590000411     Document Type: Article

References (39)

1. The epidemiology of breast cancer
2. Analysis of breast cancer mortality and stage distribution by age for the health insurance plan clinical trial
3. Reduction in mortality from breast cancer after mass screening with mammography
4. Progress in early breast cancer detection
5. Breast imaging
6. Nonpalpable breast lesions: Accuracy of prebiopsy mammographic diagnosis
7. Benign versus malignant solid breast masses: US differentiation
8. The status of mammographically guided fine needle aspiration biopsy of non-palpable breast lesions
9. 99mTcsestamibi in tumor imaging
10. Prone scintimmamography in patients with suspicion of carcinoma of the breast
11. Scintimammography with technetium-99m methoxyisobutyl isonitrile: Results of a prospective European multicenter trial
12. Sensitivity of contrast enhanced MR imaging of the breast
13. MR imaging of the breast
14. MR imaging of the breast comparison with mammography and ultrasound
15. Reporting system
16. Breast disease: Tissue characterization with Gd-DTPA enhancement profiles
17. The meaning and use of the area under a receiver operating characteristic (ROC) curve
18. Scintimammography with technetium-99m methoxyisobutylisonitrile: Comparison with mammography and magnetic resonance imaging
19. Variability in radiologists' interpretation of mammograms
20. Benign versus malignant breast disease: Comparison of contrast enhanced MR imaging and Tc99m tetrofosmin scintimammography
21. Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography
22. Dynamic contrast-enhanced magnetic resonance imaging reveals stress induced angiogenesis in MCF7 human breast tumors
23. Contrast-enhanced MRI of the breast in patients with postoperative scarring or silicon implants
24. Contrast-enhanced MRI of the breast after limited surgery and radiation therapy
25. MR imaging of the breast with Gd-DTPA: Use and limitations
26. Nonpalpable breast tumors: Diagnosis with contrast-enhanced subtraction dynamic MR imaging
27. Breast MR imaging with commercially available techniques: Radiologic-pathologic correlation
28. MR imaging of the breast: Fast imaging sequences with and without Gd-DTPA
29. Dynamic breast MR imaging: Are signal intensity time course data useful for differential diagnosis of enhancing lesions?
30. MRI of the breast: State of the art
31. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured mouse fibroblast
32. The use of technetium-99m-methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses
33. Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer
34. Scintimammography: The complementary role of Tc99m-sestamibi prone breast imaging for the diagnosis of breast carcinoma
35. Dynamic imaging: Scintimammography
36. Technetium-99m-sestamibi: An indicator of breast cancer invasiveness
37. Role of technetium-99m sestamibi scintimammography and contrastenhanced magnetic resonance imaging for the evaluation of indeterminate mammograms